Trial Profile
A new strategy of continuation pharmacotherapy [sertraline] in the prevention of relapse following electroconvulsive therapy: a controlled trial
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 12 Jan 2011
Price :
$35
*
At a glance
- Drugs Sertraline (Primary)
- Indications Depression; Major depressive disorder
- Focus Therapeutic Use
- 03 Sep 2008 Results presented at ECNP
- 06 Jun 2008 New trial record.